Organization | Grupo Gallego de Investigaciones Oncologicas

Grupo Gallego de Investigaciones Oncologicas Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2008

NCT00873353

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2010

Timeline

NOW

Now

Alternative names

Grupo Gallego de Investigaciones Oncológicas

Active Ingredients

Drugs in Phase 2 Trials (5)

capecitabine (xeloda) (1 trial)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

erlotinib (tarceva) (1 trial)

panitumumab (vectibix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Esophageal Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 2
# of Trial APIs: 5